AlphAIalphai — Financial news for AI agents
pulse2.comAUG 302 min read$HQY

HealthEquity: Adjusted EBITDA Margin Hits Record 48% As HSA Assets Grow 14% To $37.9 Billion

HealthEquity reported Q2 revenue of $350.7M, up 8% YoY. Adjusted EBITDA rose 11% to $167M, with a record margin of 48%. HSA assets grew 14% to $37.9B. Net income increased 10% to $65.6M. The company raised fiscal 2027 guidance, citing strong execution and operating leverage.

Original reporting
pulse2.com
Published Aug 30, 2026, 1:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 30, 2026, 1:18 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
HealthEquity: Adjusted EBITDA Margin Hits Record 48% As HSA Assets Grow 14% To $37.9 Billion — source image
Source · pulse2.com
Decision brief

The 30-second read

$HQYBullishHigh
01

Why it matters

The record margin and raised guidance signal operational leverage and growth, likely prompting buying interest.

02

Market read

Earnings beat and guidance raise make the stock a near‑term buying candidate.

03

What to watch

Potential regulatory changes to HSA investment rules could affect future asset growth.

Relevance 8/10Novelty 8/10Timing: post‑earnings release

Background

HealthEquity is a leading provider of health‑savings account (HSA) administration services, listed on NYSE.

Company-level read

Ticker impact

$HQYBullishHigh confidence
Context

HealthEquity reported Q2 results with record adjusted EBITDA margin and raised FY2027 guidance.

Expected impact

Expect price to rally on the news, especially in the near term.

Evidence & confidence

Margin expansion, asset growth and higher guidance indicate improved profitability and cash flow, supporting a bullish stance.

Market effects

Sector

Highlights strength in the health‑savings account sector, may boost peers with similar business models.

Regional

U.S. health‑finance niche sees positive sentiment.

Global

Limited to U.S. market; no direct global macro effect.

Counterpoint

What could challenge this read

If the market has already priced in growth, the rally could be muted; watch for valuation concerns.

Key entities

  • company
    HealthEquity

    Provider of HSA and other consumer‑directed benefit accounts.

Read at source← All news

Related articles

SEP 1
$HQYHighAI 8/10

HealthEquity (HQY) Q2 2027 Earnings Call Transcript

HealthEquity (HQY) reported Q2 2027 revenue of $350.7M, up 8% YoY, and adjusted EBITDA of $167M, up 11%. HSA assets grew 14% to $37.9B. The company raised full-year revenue guidance to $1.411B-$1.421B and adjusted EBITDA to $628M-$636M. Management highlighted growth in custodial and service revenue, as well as operational efficiencies from AI and technology investments.

fool.com3 min
AUG 30
$HQYMed

Why HealthEquity Stock Sank This Week

HealthEquity (HQY) stock fell 8.6% this week despite beating earnings and revenue estimates for Q2. The company reported adjusted EPS of $1.24 on revenue of $350.7M, up 15.7% and 7.6% YoY, respectively. Investors expected stronger guidance, as the company only slightly raised its full-year revenue target and reiterated EPS guidance.

fool.com2 min
AUG 27
$HQYHighAI 8/10

HealthEquity, Inc. Q2 2027 Earnings Call Summary

HealthEquity, Inc. reported Q2 2027 record adjusted EBITDA margins of 48% and 24% new HSA sales growth. The company raised fiscal 2027 revenue guidance to $1.411B–$1.421B and plans to roll out a next-gen app. Invested HSA assets increased 28% YoY. Management highlighted AI-driven cost reductions and Marketplace growth.

yahoo.com2 min